-transparent.png){kind=logo}
Pharmacokinetic parameters of Sch 34343 have been determined for mice, rats, rabbits, monkeys, dogs and humans and correlated among species as an exponential function of body weight. The pertinent pharmacokinetic parameters tested are apparent and steady-state volumes of distribution, total body clearance, elimination phase half-life, and mean residence time. This study showed that the extrapolation of animal data to humans on a new investigational drug, Sch 34343, can be potentially useful.
Related Publications
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
July 1994,
Pharmaceutical research,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
December 1983,
The American journal of physiology,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
July 1990,
The Journal of pharmacy and pharmacology,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
January 1990,
Drug metabolism reviews,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
January 1989,
Health physics,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
January 1984,
Drug metabolism reviews,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
August 1995,
Risk analysis : an official publication of the Society for Risk Analysis,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
April 1986,
Diagnostic microbiology and infectious disease,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
June 1985,
The Journal of antimicrobial chemotherapy,
M Chung, and
E Radwanski, and
D Loebenberg, and
C C Lin, and
E Oden, and
S Symchowicz, and
R P Gural, and
G H Miller
October 1994,
Journal of clinical pharmacology,
